Zhen Ning
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 9
- Histone Deacetylase Inhibitors Research 3
- Protein Degradation and Inhibitors 2
- Co-authors
- Aman Wang (10 shared papers)Qiu Yan (6 shared papers)Jiwei Liu (10 shared papers)Guang Tan (6 shared papers)Jinxiao Liang (3 shared papers)Chang Lu (5 shared papers)Yunpeng Xie (3 shared papers)Haifeng Luo (3 shared papers)
- Journals
- Oncology Reports (3 papers)Frontiers in Oncology (2 papers)AIDS Research and Therapy (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Zhen Ning
35 papers receiving 560 citations
Peers
Comparison fields: 5 of 104
- Cancer Research 115
- Oncology 153
- Molecular Biology 365
- Cell Biology 41
- Immunology 51
Countries citing papers authored by Zhen Ning
This map shows the geographic impact of Zhen Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Ning more than expected).
Fields of papers citing papers by Zhen Ning
This network shows the impact of papers produced by Zhen Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Ning. The network helps show where Zhen Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhen Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 55 | |
| 2 | 2017 | 49 | |
| 3 | 2014 | 44 | |
| 4 | 2014 | 42 | |
| 5 | 2014 | 37 | |
| 6 | 2017 | 35 | |
| 7 | 2021 | 31 | |
| 8 | Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis. | 2014 | 31 |
| 9 | 2018 | 28 | |
| 10 | 2017 | 27 | |
| 11 | 2019 | 21 | |
| 12 | 2022 | 19 | |
| 13 | 2021 | 18 | |
| 14 | 2022 | 16 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 13 | |
| 17 | 2024 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2022 | 9 |
About Zhen Ning
Zhen Ning is a scholar working on Molecular Biology, Epidemiology, Oncology, Artificial Intelligence and Cancer Research, having authored 38 papers that have together received 563 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), HIV/AIDS Research and Interventions (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Protein Degradation and Inhibitors (2 papers), Cancer-related Molecular Pathways (2 papers), Anomaly Detection Techniques and Applications (2 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Cancer Research (115 citations), Oncology (153 citations), Molecular Biology (365 citations), Cell Biology (41 citations) and Immunology (51 citations). Zhen Ning has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Aman Wang, Qiu Yan, Jiwei Liu, Guang Tan, Jinxiao Liang, Chang Lu, Yunpeng Xie, Jinxiao Liang, Haifeng Luo and Zhongyu Wang. Their work appears in journals such as Oncology Reports, Frontiers in Oncology, AIDS Research and Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.